ACOR News and Press, Acorda Therapeutics Inc. From 10/25/22

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a webcast/conference call in conjunction with its third quarter 2022 update and financial results on Tuesday, November 1 at 4:30 p.m. ET. To participate in the Webcast, please use the following registration link: https://eve...

Penny Stocks To Buy Now? Are you looking for penny stocks to buy now? If your answer is “yes,” you’re not alone. But before you dive headfirst into something someone on Reddit posted, you’ll want to make sure to do a few things first. For starters, find the t...

October 28, 2022 at 1pm ET, 10am PT S hareholders are invited to submit questions to the CEO Acorda Therapeutics, Inc. (Nasdaq: ACOR) will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Friday, October 28 at 1:00pm ET, 10:00am PT. The call wi...

Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the three leading, independent proxy advisory firms - Institutional Shareholder Services (ISS), Glass Lewis and Co, LLC, and Egan-Jones & Co - all recommend that shareholders vote “For” Proposal 2, Reverse St...

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will not use its common stock to make the approximately $6.2 million interest payment due on December 1, 2022, as provided for under its Convertible Senior Secured Notes Indenture. Under the terms of the agreement with...

Understanding How to Find Penny Stocks to Buy in Late October If you’re looking for penny stocks to buy right now, there are a few things you need to know. First, what is a penny stock? A penny stock is a stocks that trades for less than $5 per share. They are often volatile and ...

Best Penny Stocks To Buy This Week? What are the best penny stocks to buy this week? That’s a question I am sure you’re asking if you’re on this website. We like to allow you the ability to arrive at that decision on your own. However, in this article, we provide so...

Acorda Therapeutics ( NASDAQ: ACOR ), a biotech focused on neurological disorders, announced Sunday that a panel of arbitrators awarded it $16.5M from Alkermes ( ALKS ) in connection with a licensing dispute between the two over multiple sclerosis therapy Ampyra. ACOR shar...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com It’s time to start off the trading week with a breakdown of the biggest pre-market stock movers on Monday! Moving stocks this morning is a $16.5 million case reward, clini...

$16.5 million to recover past royalties and interest Cessation of double-digit royalty/supply payments Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that a three-judge arbitration panel has issued a final decision in a dispute with Alkermes PLC (Nasdaq...